This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Reference range (FSH)

Authoring team

IU/L

  • <1-3 prepubertal
  • 1-8 males
  • 1-11 females; follicular and luteal phase
  • 6-26 at ovulation
  • 30-118 post-menopausal

Note that reference ranges may vary between laboratories.

NICE state that with respect to the menopause and perimenopause (1):

  • diagnose the following without laboratory tests in otherwise healthy women aged over 45 years with menopausal symptoms:
    • perimenopause based on vasomotor symptoms and irregular periods
    • menopause in women who have not had a period for at least 12 months and are not using hormonal contraception
    • menopause based on symptoms in women without a uterus

  • FSH test:
    • do not use a serum follicle-stimulating hormone (FSH) test to diagnose menopause in women using combined oestrogen and progestogen contraception or high-dose progestogen

    • consider using a FSH test to diagnose menopause only:
      • in women aged 40 to 45 years with menopausal symptoms, including a change in their menstrual cycle

      • n women aged under 40 years in whom menopause is suspected

        • diagnose premature ovarian insufficiency in women aged under 40 years based on:
          • menopausal symptoms, including no or infrequent periods (taking into account whether the woman has a uterus) and
          • elevated FSH levels on 2 blood samples taken 4-6 weeks apart

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.